The basics of BIOTECH
The basics of BIOTECH
ALZHEIMER THERAPY BY MONOCLONAL ANTIBODIES
Most visited pages
Amyloid beta forms clumps in the brain of Alzheimer patients
This plays an important
role in cognitive decline
By binding to soluble beta amyloid, monoclonals may draw the peptide away from the brain through the blood
Progressive disappearance of beta amyloid might theoretically reverse cognitive decline
Five monoclonal antibodies at least are in trials:

- Ponezumab
- Gantenerumab
- Bapineuzumab
- Solanezumab
- BAN2401
Are these monoclonals aiming at the same target ?? Click to see
BREAKING NEWS: CLICK TO READ THE BEXAROTENE LATEST INFORMATION